269 related articles for article (PubMed ID: 37609076)
1. Post-translational modifications and immune responses in liver cancer.
Wang YW; Zuo JC; Chen C; Li XH
Front Immunol; 2023; 14():1230465. PubMed ID: 37609076
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between Ubiquitination and Other Post-translational Protein Modifications in Plant Immunity.
Zhang Y; Zeng L
Plant Commun; 2020 Jul; 1(4):100041. PubMed ID: 33367245
[TBL] [Abstract][Full Text] [Related]
3. Advances in post-translational modifications of proteins and cancer immunotherapy.
Li Y; Zhang R; Hei H
Front Immunol; 2023; 14():1229397. PubMed ID: 37675097
[TBL] [Abstract][Full Text] [Related]
4. Protein Modification and Autophagy Activation.
Wang R; Wang G
Adv Exp Med Biol; 2019; 1206():237-259. PubMed ID: 31776989
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of post-translational modifications in histone proteins: A review on histone modification defects in developmental and neurological disorders.
Ramazi S; Allahverdi A; Zahiri J
J Biosci; 2020; 45():. PubMed ID: 33184251
[TBL] [Abstract][Full Text] [Related]
6. Post-translational modification control of RNA-binding protein hnRNPK function.
Xu Y; Wu W; Han Q; Wang Y; Li C; Zhang P; Xu H
Open Biol; 2019 Mar; 9(3):180239. PubMed ID: 30836866
[TBL] [Abstract][Full Text] [Related]
7. Towards understanding the crosstalk between protein post-translational modifications: Homo- and heterotypic PTM pair distances on protein surfaces are not random.
Korkuć P; Walther D
Proteins; 2017 Jan; 85(1):78-92. PubMed ID: 27802577
[TBL] [Abstract][Full Text] [Related]
8. Pathological implication of protein post-translational modifications in cancer.
Pan S; Chen R
Mol Aspects Med; 2022 Aug; 86():101097. PubMed ID: 35400524
[TBL] [Abstract][Full Text] [Related]
9. Post-Translational Modification Control of Innate Immunity.
Liu J; Qian C; Cao X
Immunity; 2016 Jul; 45(1):15-30. PubMed ID: 27438764
[TBL] [Abstract][Full Text] [Related]
10. Post-Translational Modifications of G Protein-Coupled Receptors Control Cellular Signaling Dynamics in Space and Time.
Patwardhan A; Cheng N; Trejo J
Pharmacol Rev; 2021 Jan; 73(1):120-151. PubMed ID: 33268549
[TBL] [Abstract][Full Text] [Related]
11. Post-translational modifications: Regulators of neurodegenerative proteinopathies.
Gupta R; Sahu M; Srivastava D; Tiwari S; Ambasta RK; Kumar P
Ageing Res Rev; 2021 Jul; 68():101336. PubMed ID: 33775891
[TBL] [Abstract][Full Text] [Related]
12. Post-translational modifications in regulation of pathogen surveillance and signaling in plants: The inside- (and perturbations from) outside story.
Bhattacharjee S; Noor JJ; Gohain B; Gulabani H; Dnyaneshwar IK; Singla A
IUBMB Life; 2015 Jul; 67(7):524-32. PubMed ID: 26177826
[TBL] [Abstract][Full Text] [Related]
13. Post-translational modifications in bladder cancer: Expanding the tumor target repertoire.
Oo HZ; Seiler R; Black PC; Daugaard M
Urol Oncol; 2020 Dec; 38(12):858-866. PubMed ID: 30342880
[TBL] [Abstract][Full Text] [Related]
14. Post-Translational Modifications and Diabetes.
Sharma C; Hamza A; Boyle E; Donu D; Cen Y
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540730
[TBL] [Abstract][Full Text] [Related]
15. Role of Host-Mediated Post-Translational Modifications (PTMs) in RNA Virus Pathogenesis.
Kumar R; Mehta D; Mishra N; Nayak D; Sunil S
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396899
[TBL] [Abstract][Full Text] [Related]
16. Role of Post-Translational Modifications of cGAS in Innate Immunity.
Wu Y; Li S
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105828
[TBL] [Abstract][Full Text] [Related]
17. Trafficking and function of the cystic fibrosis transmembrane conductance regulator: a complex network of posttranslational modifications.
McClure ML; Barnes S; Brodsky JL; Sorscher EJ
Am J Physiol Lung Cell Mol Physiol; 2016 Oct; 311(4):L719-L733. PubMed ID: 27474090
[TBL] [Abstract][Full Text] [Related]
18. Post-translational modifications in T cells in systemic erythematosus lupus.
Yang F; Lin J; Chen W
Rheumatology (Oxford); 2021 Jun; 60(6):2502-2516. PubMed ID: 33512488
[TBL] [Abstract][Full Text] [Related]
19. Post-Translational Modifications That Drive Prostate Cancer Progression.
Samaržija I
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33572160
[TBL] [Abstract][Full Text] [Related]
20. Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies.
Wu X; Xu M; Geng M; Chen S; Little PJ; Xu S; Weng J
Signal Transduct Target Ther; 2023 May; 8(1):220. PubMed ID: 37244925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
